Advanced qPCR probes
GeneTAG Technology, Inc.
Our mission is to provide superior molecular
detection systems that are precise, simple, and inexpensive.
1. Murray JL, Hu P, Shafer DA. Seven novel probe systems for real-time PCR provide absolute single base discrimination, higher signaling, and generic components. (2014). J Mol Diagn. 16, 627–638.
2. Storts DR. Alternative Probe-Based Detection Systems in Quantitative PCR. (2014). J Mol Diagn. 16, 612-614.
GeneTAG has four patents awarded and six patents pending. These patents cover seven novel probe systems for qPCR and liquid biopsy assays, with a focus on sensitive detection of cancer-specific mutations and drug-resistant infectious diseases.
GeneTAG has been awarded 10 NIH SBIR grants to develop our novel DDS probes systems.